Notogen @NotogenInc

Notogen is biotechnology company developing regenerative therapeutics for conditions related to spinal degeneration, orthopedics and sports medicine. notogen.com Toronto, Canada Joined November 2018

Tweets

8
Followers

22
Following

5
Likes

3

Notogen @NotogenInc

3 years ago

Notogen is very pleased to announce that it has entered a worldwide research collaboration and license agreement with Boehringer Ingelheim to develop and commercialize a Notogen regenerative therapeutic for people living with degenerative disc disease. einpresswire.com/article/607927…

1 1 2 108 0

View Details

Notogen @NotogenInc

8 years ago

New CEO, Gary Margolis, believes NTG-101 "has the potential to be a game-changing treatment for disc degeneration disease.” ow.ly/2JDw30mJlqX

1 0 1 0 0

View Details

Notogen @NotogenInc

8 years ago

Notogen Appoints Gary Margolis as New Chief Executive Officer ow.ly/VxfV30mGyS6 #biotech #regenerativemedicine #biologics #drugdevelopment #notogen #NTG101

0 0 0 0 0

View Details

Notogen @NotogenInc

8 years ago

"The findings are supportive of NTG-101 as a means to impede disc degeneration, promote disc regeneration, halt inflammation, and suppress the expression of molecules secreted by discs that are known causes of pain.” -Dr. Mark Erwin #biotech #regenerativemedicine

0 0 0 0 0

View Details

Notogen @NotogenInc

8 years ago

NTG-101: A Novel Molecular Therapy that Halts the Progression of Degenerative Disc Disease ow.ly/wlyD30mCpL8 @SciReports @UofT @UAlberta @UHN

0 0 0 0 0

View Details

Notogen @NotogenInc

8 years ago

Therapeutic Potential of NTG-101, a Single Dose Injectable Treatment for Degenerative Disc Disease, Demonstrated in Preclinical Large Animal Study Published in Nature Publishing Group's “Scientific Reports” ow.ly/fZBy30mCrFL @SciReports @NatureNews